首页> 外文期刊>Molecular biology reports >Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography
【24h】

Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography

机译:大肠癌患者血清和组织中的微卫星不稳定性分型:将实时PCR与杂交探针和高效液相色谱法进行比较

获取原文
获取原文并翻译 | 示例
           

摘要

Allelic variation of BAT-25 (a 25-repeat quasimonomorphic poly T) and BAT-26 (a 26-repeat quasimonomorphic polyA) loci as two mononucleotide microsatellite markers, were analyzed with high-performance liquid chromatography (HPLC) compared with Real-Time PCR using hybridization probes. BAT-26 and BAT-25 markers were used to determine an appropriate screening technique with high sensitivity and specificity to diagnose microsatellite instability (MSI) status in patients with colorectal cancer (CRC). One of the pathways in colorectal tumor genesis is microsatellite instability (MSI+). MSI is detected in about 15 % of all CRCs; 3 % are of these are associated with Lynch syndrome and the other 12 % are caused by sporadic. Colorectal tumors with MSI have distinctive features compared with microsatellite stable tumors. Due to the high percentage of MSI+ CRC in Iran, screening of this type of CRC is imperative. Two markers were analyzed in tissues and sera of 44 normal volunteers and tumor and matched normal mucosal tissues as well as sera of 44 patients with sporadic CRC. The sensitivity and specificity of BAT-26 with real time PCR method (Hybridization probe) were 100 % in comparison with sequencing method as the gold standard, while HPLC had a lower sensitivity and specificity. According to HPLC data, BAT-26 was more sensitive than BAT-25 in identifying MSI tumors. Therefore, MSI typing using the BAT-26 hybridization probe method compared to HPLC could be considered as an accurate method for diagnosing MSI in CRC tumors but not in serum circulating DNAs.
机译:使用高效液相色谱(HPLC)与实时分析法比较了作为两个单核苷酸微卫星标记的BAT-25(25重复的准单晶多态T)和BAT-26(26重复的准单态polyA)基因座的等位基因变异。使用杂交探针的PCR。 BAT-26和BAT-25标记用于确定具有高灵敏度和特异性的合适筛查技术,以诊断大肠癌(CRC)患者的微卫星不稳定性(MSI)状态。大肠肿瘤发生的途径之一是微卫星不稳定性(MSI +)。在所有CRC中约有15%检测到MSI;其中3%与Lynch综合征相关,其余12%由零星引起。与微卫星稳定肿瘤相比,具有MSI的结直肠肿瘤具有鲜明的特征。由于伊朗的MSI + CRC比例很高,因此必须筛查此类CRC。分析了44名正常志愿者和肿瘤的组织和血清中的两种标记物,以及匹配的正常粘膜组织以及44名散发性CRC患者的血清。与作为金标准的测序方法相比,实时PCR方法(杂交探针)对BAT-26的敏感性和特异性为100%,而HPLC的敏感性和特异性较低。根据HPLC数据,在鉴定MSI肿瘤方面,BAT-26比BAT-25更为敏感。因此,与HPLC相比,使用BAT-26杂交探针法进行MSI分型可被认为是诊断CRC肿瘤而非血清循环DNA中MSI的准确方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号